Literature DB >> 21131950

Retinoid X receptor gamma signaling accelerates CNS remyelination.

Jeffrey K Huang1, Andrew A Jarjour2, Brahim Nait Oumesmar3, Christophe Kerninon3, Anna Williams2, Wojciech Krezel4, Hiroyuki Kagechika5, Julien Bauer6, Chao Zhao1, Anne Baron-Van Evercooren3, Pierre Chambon4, Charles Ffrench-Constant2, Robin J M Franklin1.   

Abstract

The molecular basis of CNS myelin regeneration (remyelination) is poorly understood. We generated a comprehensive transcriptional profile of the separate stages of spontaneous remyelination that follow focal demyelination in the rat CNS and found that transcripts that encode the retinoid acid receptor RXR-γ were differentially expressed during remyelination. Cells of the oligodendrocyte lineage expressed RXR-γ in rat tissues that were undergoing remyelination and in active and remyelinated multiple sclerosis lesions. Knockdown of RXR-γ by RNA interference or RXR-specific antagonists severely inhibited oligodendrocyte differentiation in culture. In mice that lacked RXR-γ, adult oligodendrocyte precursor cells efficiently repopulated lesions after demyelination, but showed delayed differentiation into mature oligodendrocytes. Administration of the RXR agonist 9-cis-retinoic acid to demyelinated cerebellar slice cultures and to aged rats after demyelination caused an increase in remyelinated axons. Our results indicate that RXR-γ is a positive regulator of endogenous oligodendrocyte precursor cell differentiation and remyelination and might be a pharmacological target for regenerative therapy in the CNS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21131950      PMCID: PMC4013508          DOI: 10.1038/nn.2702

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  40 in total

1.  Lysolecithin induces demyelination in vitro in a cerebellar slice culture system.

Authors:  Eric Birgbauer; Tadimeti S Rao; Michael Webb
Journal:  J Neurosci Res       Date:  2004-10-15       Impact factor: 4.164

2.  Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells.

Authors:  G Wolswijk
Journal:  J Neurosci       Date:  1998-01-15       Impact factor: 6.167

3.  Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

Authors:  Ansi Chang; Wallace W Tourtellotte; Richard Rudick; Bruce D Trapp
Journal:  N Engl J Med       Date:  2002-01-17       Impact factor: 91.245

4.  Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse.

Authors:  N S Brown; A Smart; V Sharma; M L Brinkmeier; L Greenlee; S A Camper; D R Jensen; R H Eckel; W Krezel; P Chambon; B R Haugen
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

5.  The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation.

Authors:  Fraser J Sim; Chao Zhao; Jacques Penderis; Robin J M Franklin
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

6.  Retinoid X receptor gamma-deficient mice have increased skeletal muscle lipoprotein lipase activity and less weight gain when fed a high-fat diet.

Authors:  Bryan R Haugen; Dalan R Jensen; Vibha Sharma; Leslie K Pulawa; William R Hays; Wojciech Krezel; Pierre Chambon; Robert H Eckel
Journal:  Endocrinology       Date:  2004-04-15       Impact factor: 4.736

7.  Stimulation of the myelin basic protein gene expression by 9-cis-retinoic acid and thyroid hormone: activation in the context of its native promoter.

Authors:  P M Pombo; D Barettino; N Ibarrola; S Vega; A Rodríguez-Peña
Journal:  Brain Res Mol Brain Res       Date:  1999-01-22

8.  Remyelination capacity of the MS brain decreases with disease chronicity.

Authors:  T Goldschmidt; J Antel; F B König; W Brück; T Kuhlmann
Journal:  Neurology       Date:  2009-06-02       Impact factor: 9.910

Review 9.  International Union of Pharmacology. LXIII. Retinoid X receptors.

Authors:  Pierre Germain; Pierre Chambon; Gregor Eichele; Ronald M Evans; Mitchell A Lazar; Mark Leid; Angel R De Lera; Reuben Lotan; David J Mangelsdorf; Hinrich Gronemeyer
Journal:  Pharmacol Rev       Date:  2006-12       Impact factor: 25.468

10.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.

Authors:  K D McCarthy; J de Vellis
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

View more
  196 in total

Review 1.  The retinoid X receptors and their ligands.

Authors:  Marcia I Dawson; Zebin Xia
Journal:  Biochim Biophys Acta       Date:  2011-10-01

2.  An RXR-γ Rx for white-matter damage.

Authors:  Vittorio Gallo; Li-Jin Chew
Journal:  Nat Neurosci       Date:  2011-01       Impact factor: 24.884

3.  CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination.

Authors:  Kevin S Carbajal; Juan L Miranda; Michelle R Tsukamoto; Thomas E Lane
Journal:  Glia       Date:  2011-08-09       Impact factor: 7.452

Review 4.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

Review 5.  Essential Dietary Bioactive Lipids in Neuroinflammatory Diseases.

Authors:  Maria Valeria Catani; Valeria Gasperi; Tiziana Bisogno; Mauro Maccarrone
Journal:  Antioxid Redox Signal       Date:  2017-07-24       Impact factor: 8.401

6.  Critical role for PAR1 in kallikrein 6-mediated oligodendrogliopathy.

Authors:  Joshua E Burda; Maja Radulovic; Hyesook Yoon; Isobel A Scarisbrick
Journal:  Glia       Date:  2013-07-08       Impact factor: 7.452

7.  Cocaine-induced loss of white matter proteins in the adult mouse nucleus accumbens is attenuated by administration of a β-lactam antibiotic during cocaine withdrawal.

Authors:  Jane Kovalevich; Gladys Corley; William Yen; Scott M Rawls; Dianne Langford
Journal:  Am J Pathol       Date:  2012-09-29       Impact factor: 4.307

Review 8.  Current advancements in promoting remyelination in multiple sclerosis.

Authors:  David Kremer; Rainer Akkermann; Patrick Küry; Ranjan Dutta
Journal:  Mult Scler       Date:  2018-10-01       Impact factor: 6.312

Review 9.  The evidence for a beneficial role of vitamin A in multiple sclerosis.

Authors:  Yara Dadalti Fragoso; Patrick N Stoney; Peter J McCaffery
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

Review 10.  Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Cell Mol Neurobiol       Date:  2017-09-13       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.